Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
FDA advisers support conditional clearance of Biogen’s ALS drug
BioPharma Dive
Wednesday, March 22, 2023 - 9:23pm
tags:
Biogen, ALS, FDA, tofersen
VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced
Fierce Biotech
Wednesday, March 22, 2023 - 9:21pm
tags:
VistaGen, nasal spray, social anxiety, open-label, PH94B
Apple vs. AliveCor and the Evolution of Wearable Medical Devices
Medical Devices and Diagnostics Industry
Wednesday, March 22, 2023 - 9:18pm
tags:
Medtech, wearables, Apple, AliveCor, patents
Moderna CEO defends price of COVID shot at Senate hearing
BioPharma Dive
Wednesday, March 22, 2023 - 9:16pm
tags:
Moderna Therapeutics, vaccines, COVID-19, drug pricing, Senate, Bernie Sanders, Stephane Bancel
After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court
Fierce Pharma
Wednesday, March 22, 2023 - 9:15pm
tags:
JNJ, legal, Supreme Court, bankruptcy
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Wednesday, March 22, 2023 - 9:11pm
tags:
Novartis, clinical trials, Leqvio, UK, Cardiovascular
New Medical Device Startup Launched in Spain
Medical Devices and Diagnostics Industry
Wednesday, March 22, 2023 - 9:10pm
tags:
Conus Airway, Spain, devices, Medtech, respiratory surgery
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wednesday, March 22, 2023 - 11:19am
tags:
Pfizer, Astellas, Xtandi, prostate cancer, drug pricing, NIH, march-in rights
FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up
Fierce Pharma
Wednesday, March 22, 2023 - 11:14am
tags:
Regeneron, Evkeeza, pediatric, Homozygous Familial Hypercholesterolemia, FDA
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
Enpoints
Wednesday, March 22, 2023 - 11:13am
tags:
Dewpoint Therapeutics, Novo Nordisk, diabetes, insulin resistance, condensates
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint
NJ Business
Wednesday, March 22, 2023 - 11:12am
tags:
BeiGene, New Jersey, R&D, drug manufacturing
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
PM Live
Wednesday, March 22, 2023 - 10:15am
tags:
Roche, Eli Lilly, Alzheimer's disease, diagnostics
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wednesday, March 22, 2023 - 10:13am
tags:
Flare Therapeutics, funding, Pfizer, Eli Lilly, Novartis, transcription factors
Medtronic, NVIDIA to combine forces on AI devices, allowing users to create new software
Medtech Dive
Wednesday, March 22, 2023 - 10:11am
tags:
Medtronic, Medtech, NVIDIA, artificial intelligence, devices, medical software
Boston Scientific, Medtronic expected to quickly capture new atrial fibrillation market: analysts
Medtech Dive
Wednesday, March 22, 2023 - 10:09am
tags:
Boston Scientific, Medtronic, Medtech, pulsed field ablation, atrial fibrillation
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Wednesday, March 22, 2023 - 10:07am
tags:
Genentech, EpiBiologics, protein degradation
89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround
Endpoints
Wednesday, March 22, 2023 - 10:05am
tags:
89Bio, NASH, clinical trials, gozafermin, Akero Therapeutics
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wednesday, March 22, 2023 - 10:03am
tags:
AACR, Moderna Therapeutics, Allogene, AstraZeneca, Merck, Roche, Novartis, Eli Lilly, Innovent, Springworks, Biogene, Relay Therapeutics, Vivace Therapeutics
Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business
Fierce Pharma
Tuesday, March 21, 2023 - 10:03pm
tags:
Baxter, Thermofisher, Celltrion, M&A, CMOs
FDA to soon decide on second round of Omicron-tailored boosters
Reuters
Tuesday, March 21, 2023 - 10:00pm
tags:
COVID-19, vaccines, boosters, Omicron, FDA

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)
Drug Channels
Winning the Race for Patient Access: Identifying Copay Accumulator Impact
Drug Channels
Gene Drives Are Coming
In the Pipeline
Organizing Our Thoughts About Cells - Finally
In the Pipeline
Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists
Drug Channels
The Right Assay With the Right Cells
In the Pipeline
Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress
Drug Channels
Peptide-Encoded Screening Libraries
In the Pipeline
It's Not All Bad News: Data Shows There's a Collaborative Future for 340B
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information